1
|
Carpenito L, D'Ercole M, Porta F, Di Blasi E, Doi P, Fagara GR, Rey R, Bulfamante G. The autopsy at the time of SARS-CoV-2: Protocol and lessons. Ann Diagn Pathol 2020; 48:151562. [PMID: 32653819 PMCID: PMC7334655 DOI: 10.1016/j.anndiagpath.2020.151562] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Revised: 06/17/2020] [Accepted: 06/21/2020] [Indexed: 01/09/2023]
Abstract
A new viral disease named COVID-19 has recently turned into a pandemic. Compared to a common viral pneumonia it may evolve in an atypical way, causing the rapid death of the patient. For over two centuries, autopsy has been recognized as a fundamental diagnostic technique, particularly for new or little-known diseases. To date, it is often considered obsolete giving the inadequacy to provide samples of a quality appropriate to the sophisticated diagnostic techniques available today. This is probably one of the reasons why during this pandemic autopsies were often requested only in few cases, late and discouraged, if not prohibited, by more than one nation. This is in contrast with our firm conviction: to understand the unknown we must look at it directly and with our own eyes. This has led us to implement an autopsy procedure that allows the beginning of the autopsy shortly after death (within 1–2 h) and its rapid execution, also including sampling for ultrastructural and molecular investigations. In our experience, the tissue sample collected for diagnosis and research were of quality similar to biopsy or surgical resections. This procedure was performed ensuring staff and environmental safety. We want to propose our experience, our main qualitative results and a few general considerations, hoping that they can be an incentive to use autopsy with a new procedure adjusted to match the diagnostic challenges of the third millennium. Early performed autopsy (within 1-2 hour from death) provides tissue samples for diagnosis and research of quality similar to biopsy or surgical resections. Early samples collection reduces post-mortem artifacts, thus preventing the wrong interpretation of the morphological pictures observed. Precise autopsy planning prevents risks for the staff.
Collapse
Affiliation(s)
- L Carpenito
- School of Pathology, University of Milan, Milan, Italy.
| | - M D'Ercole
- School of Pathology, University of Milan, Milan, Italy
| | - F Porta
- School of Pathology, University of Milan, Milan, Italy
| | - E Di Blasi
- School of Pathology, University of Milan, Milan, Italy
| | - P Doi
- Complex Unit of Pathological Anatomy and Medical Genetics, San Paolo Hospital, University of Milan, Milan, Italy
| | - G Redolfi Fagara
- Complex Unit of Pathological Anatomy and Medical Genetics, San Paolo Hospital, University of Milan, Milan, Italy
| | - R Rey
- Complex Unit of Pathological Anatomy and Medical Genetics, San Paolo Hospital, University of Milan, Milan, Italy
| | - G Bulfamante
- Complex Unit of Pathological Anatomy and Medical Genetics, San Paolo Hospital, University of Milan, Milan, Italy
| |
Collapse
|
2
|
Faioni EM, Fontana G, Razzari C, Avagliano L, Bulfamante G, Calvi E, Doi P, Marconi AM. Activation of Protein C in Human Trophoblasts in Culture and Downregulation of Trophoblast Endothelial Protein C Receptor by TNF-α. Reprod Sci 2015; 22:1042-8. [PMID: 25667200 DOI: 10.1177/1933719115570904] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
In mice, trophoblasts are equipped with a potent anticoagulant mechanism, the protein C pathway. In human placenta, no functional studies of the protein C pathway are available. Human first-trimester trophoblasts (CK(++) HLA-G(+/-) Vim(-)) were isolated and kept in culture for a maximum of 48 hours. Activation of protein C on trophoblasts was at least as efficient as in endothelial cells (4.43 × 10 (-) (7) nmol/L/min/cell). Endothelial protein C receptor (EPCR) was expressed in syncytiotrophoblasts and extravillous trophoblasts. Downregulation of the messenger RNA of trophoblast EPCR occurred when trophoblasts were challenged with tumor necrosis factor α, and it could be prevented by unfractionated heparin but not by low-molecular-weight heparin at therapeutic doses. In conclusion, there is a functional protein C pathway on human first-trimester trophoblasts which can be modulated by inflammation. This finding has implications for the pathogenesis and prevention of placenta-mediated obstetric complications.
Collapse
Affiliation(s)
- E M Faioni
- Servizio di Immunoematologia e Medicina Trasfusionale, Azienda Ospedaliera San Paolo, Polo Universitario, Italy Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy
| | - G Fontana
- Servizio di Immunoematologia e Medicina Trasfusionale, Azienda Ospedaliera San Paolo, Polo Universitario, Italy Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy
| | - C Razzari
- Servizio di Immunoematologia e Medicina Trasfusionale, Azienda Ospedaliera San Paolo, Polo Universitario, Italy Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy
| | - L Avagliano
- Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy U.O. Ostetricia e Ginecologia, Azienda Ospedaliera San Paolo, Polo Universitario, Italy
| | - G Bulfamante
- Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy U.O. Anatomia Patologica, Azienda Ospedaliera San Paolo, Polo Universitario, Italy
| | - E Calvi
- Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy U.O. Ostetricia e Ginecologia, Azienda Ospedaliera San Paolo, Polo Universitario, Italy
| | - P Doi
- Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy U.O. Anatomia Patologica, Azienda Ospedaliera San Paolo, Polo Universitario, Italy
| | - A M Marconi
- Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy U.O. Ostetricia e Ginecologia, Azienda Ospedaliera San Paolo, Polo Universitario, Italy
| |
Collapse
|
3
|
Avagliano L, Danti L, Doi P, Felis S, Guala M, Locatelli A, Maffeo I, Mecacci F, Plevani C, Simeone S, Bulfamante G. Autophagy in placentas from acidotic newborns: An immunohistochemical study of LC3 expression. Placenta 2013; 34:1091-4. [DOI: 10.1016/j.placenta.2013.09.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2013] [Revised: 09/02/2013] [Accepted: 09/05/2013] [Indexed: 01/08/2023]
|
4
|
Soroceanu L, Cobbs CS, Colapietro P, Pileri P, Colleoni F, Avagliano L, Doi P, Bulfamante G, Miozzo M, Cetin I. Is HCMV a tumor promoter? Virus Res 2010; 157:193-203. [PMID: 21036194 DOI: 10.1016/j.virusres.2010.10.026] [Citation(s) in RCA: 142] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2010] [Revised: 10/14/2010] [Accepted: 10/19/2010] [Indexed: 12/16/2022]
Abstract
Human cytomegalovirus (HCMV) is a beta-herpesvirus that causes persistent infection in humans and can cause severe disease in fetuses and immunocompromised individuals. Although HCMV is not currently causally implicated in human cancer, emerging evidence suggests that HCMV infection and expression may be specifically associated with human malignancies including malignant glioma, colon, and prostate cancer. In addition, multiple investigators have demonstrated that HCMV can dysregulate signaling pathways involved in initiation and promotion of malignancy, including tumor suppressor, mitogenic signaling, inflammatory, immune regulation, angiogenesis and invasion, and epigenetic mechanisms. This review highlights some of the recent evidence that HCMV might play a role in modulating the tumor microenvironment as well as in the initiation and promotion of tumor cells themselves.
Collapse
Affiliation(s)
- Liliana Soroceanu
- California Pacific Medical Center Research Institute, 475 Brannan Street, Suite 220, San Francisco, CA 94107, USA. liliana
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Garzia E, Borgato S, Cozzi V, Doi P, Bulfamante G, Persani L, Cetin I. Lack of expression of endometrial prolactin in early implantation failure: a pilot study. Hum Reprod 2004; 19:1911-6. [PMID: 15218000 DOI: 10.1093/humrep/deh350] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Animal models and experimental studies suggest a role for paracrine prolactin (PRL) signalling in decidualization and embryo implantation. We investigated the expression of endometrial prolactin (e-PRL) and prolactin receptor (PRL-R) in the endometrium of women affected by unexplained infertility (UI) and repeated miscarriages (RM). METHODS Patients (n = 24) were divided into three groups: RM, n = 5; UI, n = 11; controls, n = 8. Endometrial samples were collected at the time of hysteroscopy in the late luteal phase. The presence of transcripts of e-PRL and PRL-R was investigated by qualitative RT-PCR. Pattern and site of expression of e-PRL were studied by immunohistochemistry. RESULTS PRL-R mRNA was detected in all endometrial samples of the three groups. PRL gene expression was detected in all control samples, only in three of five samples of the RM group and in four of 11 samples of the UI group. RT-PCR results were largely confirmed by immunohistochemistry, study groups showing a defect of expression of e-PRL. CONCLUSIONS In this pilot study we report a lack of expression of endometrial prolactin during the 'implantation window' in some patients affected by unexplained infertility and repeated miscarriages. These data, in association with those obtained in experimental animals, suggest that the lack of endometrial PRL expression is involved in reproduction failure.
Collapse
Affiliation(s)
- E Garzia
- Department of Medicine, Surgery and Dentistry, University of Milan, San Paolo Hospital, via di Rudinì, 8, 20142 Milan, Italy
| | | | | | | | | | | | | |
Collapse
|
6
|
Tripputi P, Cassani B, Alfano R, Graziani D, Cigognini D, Doi P, Bignotto M, Corneo G, Coggi G. Chromosome 7 monosomy and deletions in myeloproliferative diseases. Leuk Res 2001; 25:735-9. [PMID: 11489466 DOI: 10.1016/s0145-2126(01)00012-1] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
We studied deletion and monosomy of chromosome 7 in 150 patients with myeloproliferative diseases. We found 8/150 patients with monosomy 7 by cytogenetics and 4/150 with deletions of the long arm of chromosome 7 by restriction fragment length polymorphism (RFLP) analysis performed with Southern and polymerase chain reaction. To overcome limitation of RFLP analysis, we restricted loss of heterozygosity study with microsatellites to 45 patients, observing deletion 7q31.1 in 7/45 patients. In all patients with molecular alterations the deletion was observed only in myeloid cells, while the monosomy was detected in both myeloid precursor and lymphocytes. This finding suggests a CD34-totipotent stem cell origin for the monosomy and a colony forming unit - granulocyte, erythrocyte, monocyte, megakaryocytes (CFU-GEMM) stem cell origin for the deletions.
Collapse
Affiliation(s)
- P Tripputi
- Department of Medicine, Surgery and Dentistry, University of Milan, Ospedale San Paolo, via A. di Rudinì 8, 20142, Milano, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Tennis P, Andrews E, Bombardier C, Wang Y, Strand L, West R, Tilson H, Doi P. Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the Province of Saskatchewan, Canada. J Clin Epidemiol 1993; 46:685-95. [PMID: 8326357 DOI: 10.1016/0895-4356(93)90049-7] [Citation(s) in RCA: 55] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The objective of this effort was to assess the utility of the large automated database in Saskatchewan as a resource for pharmacoepidemiologic studies. To this end a study was undertaken to test the hypothesis that rheumatoid arthritis (RA) increases the risk of cancer, especially lymphoma. This was done by performing a retrospective cohort study based on record linkage data from Saskatchewan Health. From hospital discharge diagnoses in the hospital file an exposed group (RA) and two comparison groups matched to the RA group by age and sex were identified: (1) the RA group consisted of people with a discharge diagnosis of rheumatoid arthritis; (2) the osteoarthritis (OA) group consisted of people with OA discharge diagnoses; and (3) a comparison (CN) group consisted of hospitalized people with no discharge diagnoses of arthritis. Drug exposures were determined by linkage with the Prescription Drug File, cancer outcomes were determined by linkage with the Cancer Foundation file, and length of eligibility in the health plan and demographics information were determined by linkage with the registration file. The data were checked for quality of linkages across files and consistency with study definitions. Of 13,333 identified subjects, 2.8% were excluded because of apparent incorrect assignment to study group or age group or because of ineligibility in health plan during the study period. In order to decrease the possibility of misclassification of exposure (rheumatoid arthritis), hospital discharge diagnoses were used to exclude subjects with any inflammatory rheumatic diseases (IRD) from the CN (7.8%) and OA (8.3%) groups and subjects with IRD other than rheumatoid arthritis (4.6%) from the RA group. To decrease selection bias, those who had cancer within 1 year of enrollment (to exclude those in hospital because of symptoms of undiagnosed cancer) were excluded. Because RA subjects hospitalized by a rheumatologist were most likely to have valid rheumatoid arthritis diagnoses, each analysis was run twice: once with the entire RA group (N = 1210) and once with those in the RA group who were rheumatologist-hospitalized (N = 646). Logistic regression of incidence was used to control for age, sex, and use of individual disease-modifying anti-rheumatoid drugs (DMARDs). For the rheumatologist-hospitalized RA group compared to the CN group, a significant 4-fold greater risk for lymphoma/myeloma was detected when DMARD use was not controlled for, and a 3.4-fold increase in risk was detected even when use of individual DMARDs was controlled for.(ABSTRACT TRUNCATED AT 400 WORDS)
Collapse
Affiliation(s)
- P Tennis
- ESP Division, Burroughs Wellcome Co., Research Triangle Park, NC 27709
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Garagna S, Redi CA, Capanna E, Andayani N, Alfano RM, Doi P, Viale G. Genome distribution, chromosomal allocation, and organization of the major and minor satellite DNAs in 11 species and subspecies of the genus Mus. Cytogenet Cell Genet 1993; 64:247-55. [PMID: 8404050 DOI: 10.1159/000133587] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
We compared the genome distribution, chromosomal allocation, and organization of the major and minor satellite DNAs (satDNAs) in 11 species and subspecies of the genus Mus. Southern blot analysis of the major and minor satDNAs showed similar fragment profiles in all 11 species, with the exception of M. cervicolor and M. cookii for the major satDNAs and M. caroli, M. cervicolor, and M. cookii for the minor satDNAs, where these sequences could not be detected by the probes used. In situ hybridization of the major and minor satDNA probes revealed chromosome-specific allocations of these sequences with quantitative species-specific patterns. Fluorometric analysis of the organization of the satellite sequences suggested that in the M. domesticus genome satDNA sequences are clustered in tandem repeats that are longer than those present in other Mus genomes. When compared with the other Mus genomes so far studied, the domesticus genome shows the highest quantity of satDNA sequences with a long-range organization of satDNA sequences.
Collapse
Affiliation(s)
- S Garagna
- Dipartimento di Biologia Animale, Universitá di Pavia, Italy
| | | | | | | | | | | | | |
Collapse
|
9
|
Creagh-Kirk T, Doi P, Andrews E, Nusinoff-Lehrman S, Tilson H, Hoth D, Barry DW. Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program. JAMA 1988; 260:3009-15. [PMID: 3263514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Through a compassionate plea program (Treatment Investigational New Drug), 4805 patients with acquired immunodeficiency syndrome who previously had experienced Pneumocystis carinii pneumonia (PCP) received zidovudine (Retrovir, formerly azidothymidine). Overall survival at 44 weeks after initiation of therapy was 73% (+/- 2.1%). A positive association was found between survival and pretherapy clinical status as defined by hemoglobin level, functional ability, and stage of disease as measured by time since diagnosis of PCP. For patients with baseline hemoglobin levels of 120 g/L or greater, Karnofsky scores of 90 or greater, and PCP diagnosis within 90 days prior to initiation of therapy, 44-week survival was 88%. Adverse clinical experiences associated with zidovudine therapy were consistent with those from a double-blind, placebo-controlled trial. Survival experience of this large and diverse cohort is consistent with, and extends data from, this clinical trial. Comparison with available natural history data suggests that zidovudine therapy is associated with increased 44-week survival of post-PCP patients with acquired immunodeficiency syndrome.
Collapse
Affiliation(s)
- T Creagh-Kirk
- Burroughs Wellcome Co. Research Triangle Park, NC 27709
| | | | | | | | | | | | | |
Collapse
|